Use of off-label and unlicensed medicines in neonatal intensive care.
Haline Tereza Matias de Lima CostaTatiana Xavier da CostaRand Randall MartinsAntônio Gouveia OliveiraPublished in: PloS one (2018)
Although there are actions to encourage the development of pharmacological studies with neonates, this study observed a high rate of prescription and exposure of newborns to off-label and unlicensed drugs in NICUs and pointed out areas of neonatal therapy that require scientific investment.